NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-097-1995-0-PCT-02 METHODS OF TREATING ESTABLISHED COLITIS USING ANTIBODIES AGAINST IL-12 PCT PCT PCT/US1996/004337 Expired
NCI E-086-1995-0-PCT-02 O-MALONYLTYROSYL COMPOUNDS, O-MALONYTYRISYL COMPOUND CONTAINING PEPTIDES, AND USES THEREOF PCT PCT PCT/US1996/004311 Expired
NIAID E-097-1995-0-JP-15 METHODS OF TREATING ESTABLISHED COLITIS USING ANTIBODIES AGAINST IL-12 JP DIV 2007-305065 Abandoned
NIMH E-121-1995-0-US-01 SUSCEPTIBILITY GENES FOR BIPOLAR AFFECTIVE DISORDER US 60/014,334 Abandoned
NCI E-149-1993-1-US-01 PARTIAL INTRON SEQUENCE OF VON HIPPEL-LINDAU (VHL) DISEASE GENE AND ITS USE IN DIAGNOSIS OF DISEASE US CIP 08/623,428 6312890 Expired PDF
NCI E-093-1995-0-AU-03 T-CELL RECEPTORS AND THEIR USE IN THERAPEUTIC AND DIAGNOSTIC METHODS AU National Stage 53736/96 Expired
NCI E-093-1995-0-PCT-02 T-CELL RECEPTORS AND THEIR USE IN THERAPEUTIC AND DIAGNOSTIC METHODS PCT PCT PCT/US1996/004143 Expired
NCI E-040-1992-2-US-03 TREATMENT OF TUMORS BY GENETIC TRANSFORMATION OF TUMOR CELLS WITH GENES ENCODING NEGATIVE SELECTIVE MARKERS AND CYTOKINES US National Stage 08/632,453 Abandoned
NCI E-093-1995-0-JP-06 T-CELL RECEPTORS AND THEIR USE IN THERAPEUTIC AND DIAGNOSTIC METHODS JP National Stage 529603/96 Abandoned
NCI E-093-1995-0-CA-04 T-CELL RECEPTORS AND THEIR USE IN THERAPEUTIC AND DIAGNOSTIC METHODS CA National Stage 2217009 Abandoned
NCI E-116-1996-0-US-01 INHIBITION OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE BY GUANOSINE QUARTE STRUCTURES US 60/014,007 Abandoned
NIDDK E-279-2000-0-PCT-02 Novel Compositions For The Treatment of Heart Failure PCT PCT PCT/US96/03911 Expired
NCI E-076-1996-0-US-01 ABNORMAL CENTROSOME DUPLICATION IN THE ABSENCE OF P53 US 60/014,728 Abandoned
NCI E-075-1996-0-US-01 METHODS AND COMPOSITIONS OF CHIMERIC POLYPEPTIDES FOR TUMOR ANTIGEN VACCINES US 60/013,839 Abandoned
NCI E-062-1996-0-US-01 Prostate Specific Antigen Oligo-Epitope Peptide US ORD 08/618,936 6946133 Expired PDF
NCI E-071-1991-1-US-03 METHOD FOR THE TREATMENT OF CANCER US DIV 08/618,863 6150398 Expired PDF
NCI E-035-1996-0-US-01 METHOD OF TREATING CANCER USING 26-EPIBRYOSTATIN AND ANALOGUES THEREOF US 60/013,740 Abandoned
NCI E-157-1994-1-US-01 METHODS AND COMPOSITIONS FOR DETECTING DIHYROPYRIMIDINE DEHYDROGENASE SPLICING MUTATIONS US 60/013,835 Abandoned
NCI E-115-1996-0-US-01 IMPORTANCE OF THE ZINC FINGER OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE IN BINDING TO AND INHIBITION BY GUANOSINE QUARTER STRUCTURES US 60/013,688 Abandoned
NICHD E-017-1995-0-AU-03 METHOD FOR PREPARING 17ALPHA-ACETOXY-11BETA-(4-N,N-DIMETHYLAMINOPHYL)- 19-NORPREGNA-4,9-DIENE-3,20-DIONE, INTERMEDIATES USEFUL IN THE... AU National Stage 53145/96 Abandoned
NCI E-157-1993-1-US-02 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE US CON 08/617,421 5736527 Abandoned PDF
NICHD E-017-1995-0-PCT-02 No_Patent_Title PCT PCT PCT/US96/03660 Expired
NICHD E-017-1995-0-EP-05 METHOD FOR PREPARING 17ALPHA-ACETOXY-11BETA-(4-N,N-DIMETHYLAMINOPHYL)- 19-NORPREGNA-4,9-DIENE-3,20-DIONE, INTERMEDIATES USEFUL IN THE... EP National Stage 96909749.2 Abandoned
NICHD E-017-1995-0-CA-04 METHOD FOR PREPARING 17ALPHA-ACETOXY-11BETA-(4-N,N-DIMETHYLAMINOPHYL)- 19-NORPREGNA-4,9-DIENE-3,20-DIONE, INTERMEDIATES USEFUL IN THE... CA National Stage 2216737 Abandoned
NINDS E-173-1992-0-US-03 CONVECTION-ENHANCED DRUG DELIVERY US FWC 08/616,785 5720720 Expired PDF
NIAID E-054-1996-0-US-01 METHODS FOR DETECTING ANTIBODIES TO HAV 3C PROTEINASE US 60/013,333 Abandoned
NCI E-206-1995-2-US-01 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PEPTIDE PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY US 60/013,172 Abandoned
NCI E-078-1993-0-US-24 ANTIVIRAL NAPHTHOQUINONE COMPOUNDS, COMPOSITIONS AND USES THEREOF US CON 08/613,162 5783598 Abandoned PDF
NCI E-234-1992-2-US-01 PROCESS FOR DETECTING ALZHEIMER DISEASE USING CULTURED CELLS US CIP 08/611,330 5773219 Abandoned PDF
NCI E-199-1992-0-US-03 MONOTERPENES, SESQUITERPENES AND DITERPENES AS CANCER THERAPY US CON 08/611,543 Abandoned
NIDDK E-163-1991-1-US-03 A METHOD FOR REDUCING THE IMMUNOGENICITY OF ANTIBODY VARIABLE DOMAINS US FWC 08/609,218 Abandoned
NCI E-046-1994-0-US-10 FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS US FWC 08/613,743 6403769 Expired PDF
NCI E-154-1995-0-US-01 RECOMBINANT RIBONUCLEASE PROTEINS US 60/011,800 Abandoned
NCI E-221-1994-0-US-01 PEPTIDOMIMETIC INHIBITORS OF CATHEPSIN D AND PLASMEPSINS I AND II US ORD 08/603,737 5849691 Abandoned PDF
NCI E-033-1995-0-PCT-02 No_Patent_Title PCT PCT PCT/US96/02336 Abandoned
NCI E-038-1995-0-PCT-02 No_Patent_Title PCT PCT PCT/US96/02134 Abandoned
NCI E-135-1999-0-US-01 Vaccines for B Cell Malignancies US 60/011,783 Abandoned
NIDDK E-227-1995-0-US-01 RNase L Activators and Antisense Oligonucleotides Effective to Treat RSV Infections US 60/011,725 Abandoned
NCI E-067-1995-0-CA-04 A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASEs BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSSS LINKING... CA National Stage 2212888 Expired
NCI E-067-1995-0-DK-11 METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN... DK EP 96905555.7 Abandoned
NCI E-067-1995-0-GB-16 METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN... GB EP 96905555.7 Abandoned
NCI E-067-1995-0-BE-10 METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN... BE EP 96905555.7 Abandoned
NCI E-067-1995-0-AT-07 METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN... AT EP 96905555.7 Abandoned
NCI E-067-1995-0-DE-08 METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN... DE EP 96905555.7 Abandoned
NCI E-067-1995-0-FR-13 METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN... FR EP 96905555.7 Abandoned
NCI E-067-1995-0-IT-17 METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN... IT EP 96905555.7 Abandoned
NCI E-067-1995-0-GR-14 METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN...9 GR EP 3041443 Abandoned
NCI E-067-1995-0-IE-15 METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN... IE EP 96905555.7 Abandoned
NCI E-067-1995-0-EP-05 METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN... EP National Stage 96905555.7 Expired
NCI E-067-1995-0-LI-09 METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN... LI EP 96905555.7 Abandoned